Pharmaceuticals Global On demand · 24-48h

Global Panax Quinquefolius Market Strategic Research Report

Global Panax Quinquefolius Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Panax Quinquefolius Market
$5.5B2025
4.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Dried Ginseng, Wet Ginseng

By Application: Medicine, Food and Health Products

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Hsu’s, WOHO, Great Mountain Ginseng, Tongrentang, Shanghai Leiyunshang Pharmaceutical, Globrand, Kangmei Xinkaihe, Canadian Ginseng Farm Shop, Rainey Ginseng Farm, Great Ontario Ginseng Farms, Chang's Ginseng Farm, Sunmore Healthtech Ltd, Canadian Vita Corporation, W Ginseng Farm, Wisconsin Grown Ginseng LLC, Schumacher Ginseng LLC, Shandong Yiyang Group, Dongfanghong American Ginseng Pharmaceutical (Tonghua) Co., Ltd, Liaoning Longshen Health Pharmaceutical Co., Ltd

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 128 pages
Market size 2025
$5.5B
Billion USD
Forecast CAGR
4.9%
2025-2032
Forecast 2032
$7.7B
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Panax Quinquefolius market size is predicted to grow from US$ 5,497 million in 2025 to US$ 7,656 million in 2032; it is expected to grow at a CAGR of 4.9% from 2026 to 2032.

Panax quinquefolius (American ginseng) is a perennial herb native to North America and belongs to the genus Panax in the family Araliaceae. The dried root is the medicinal part and is valued for its effects in replenishing Qi, nourishing Yin, and relieving internal heat. Compared with Asian ginseng (Panax ginseng), American ginseng has a cooler nature and is commonly used to reduce fatigue, enhance immunity, and regulate the central nervous system. Its primary active constituents are ginsenosides—particularly Rb1, Re, and Rg1—with distinctive ratios that differentiate it from Asian ginseng. In 2024, global panax quinquefolius production reached approximately 34.01 K MT, with an average global market price of around US$ 149.61 per kg. Global production capacity in 2024 was approximately 43 K MT. The upstream segment of the American ginseng industry mainly involves cultivation and primary processing. Key inputs include high-quality seeds, cultivation bases (usually shade-grown farms), fertilizers, and agricultural materials. Because American ginseng requires specific soil and climatic conditions, production is concentrated in Wendeng (Shandong, China), Tonghua (Jilin, China), Ontario (Canada), and Wisconsin (USA). This stage also covers cleaning, drying, grading, and storage of raw roots. The downstream segment includes distribution and end markets, such as TCM processors, pharmaceutical companies, health supplement brands, e-commerce platforms, and exporters. The major consumption markets are China and other Asian countries, where American ginseng is used in traditional medicine, tonic products, and nutritional beverages. In recent years, demand has grown notably in cross-border e-commerce and functional beverage sectors.

The global American ginseng (Panax quinquefolius) market has maintained steady growth, driven by rising health awareness, expanding demand for immune-support supplements, and the internationalization of traditional Chinese medicine. Major production regions include Ontario (Canada), Wendeng in Shandong (China), and Wisconsin (USA), with China emerging as a key processing and consumption hub. Demand is concentrated in China, South Korea, and Southeast Asia, covering product forms such as decoction pieces, powders, capsules, oral liquids, and functional beverages. The industry is shifting toward branding, standardization, and deep processing, with ginseng extracts and nutraceutical formulations becoming new growth drivers. However, climatic constraints and soil rotation requirements cause raw material price fluctuations, making future development increasingly reliant on improved varieties, modern cultivation management, and global market expansion.

This report presents a comprehensive overview of the global Panax Quinquefolius market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Dried Ginseng
  • Wet Ginseng

Segment by Growth Method

  • Wild Panax Quinquefolius
  • Cultivated Panax Quinquefolius

Segment by Processing Method

  • Dried Roots
  • Sliced Ginseng
  • Powder and Extract
  • Formulated Products

Segment by Quality Grade

  • High-Ginsenoside Type
  • Standard Type
  • Low-Ginsenoside/Subgrade Type

Segment by Application

  • Medicine
  • Food and Health Products

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Panax Quinquefolius market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Medicine, Food and Health Products evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Panax Quinquefolius Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$5.5B
2025
Forecast
$7.7B
2032
CAGR
4.9%
2025–2032
Regionen
5
global
Key companies
Hsu’sWOHOGreat Mountain GinsengTongrentangShanghai Leiyunshang PharmaceuticalGlobrandKangmei XinkaiheCanadian Ginseng Farm Shop
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Dried GinsengWet Ginseng
By Application
MedicineFood and Health Products

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Dried Ginseng
  • 3.1.3 Wet Ginseng
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Medicine
  • 4.1.3 Food and Health Products
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Hsu’s
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 WOHO
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Great Mountain Ginseng
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Tongrentang
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Shanghai Leiyunshang Pharmaceutical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Globrand
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Kangmei Xinkaihe
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Canadian Ginseng Farm Shop
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Rainey Ginseng Farm
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Great Ontario Ginseng Farms
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Chang's Ginseng Farm
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Sunmore Healthtech Ltd
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Canadian Vita Corporation
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 W Ginseng Farm
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Wisconsin Grown Ginseng LLC
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Schumacher Ginseng LLC
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Shandong Yiyang Group
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Dongfanghong American Ginseng Pharmaceutical (Tonghua) Co., Ltd
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Liaoning Longshen Health Pharmaceutical Co., Ltd
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Panax Quinquefolius market?
The global Panax Quinquefolius market is estimated at US$ 5.5 billion in 2025 (base year) and is projected to reach US$ 7.66 billion by 2032.
What is the forecast CAGR for the Panax Quinquefolius market?
The market is expected to grow at a CAGR of 4.9% from 2026 to 2032, expanding from US$ 5.5 billion in 2025 to US$ 7.66 billion in 2032, roughly 1.4 times its base-year value.
What is Panax Quinquefolius?
Panax quinquefolius (American ginseng) is a perennial herb native to North America and belongs to the genus Panax in the family Araliaceae. The dried root is the medicinal part and is valued for its effects in replenishing Qi, nourishing Yin, and relieving internal heat. Compared with Asian ginseng (Panax ginseng), American ginseng has a cooler nature and is commonly used to reduce fatigue, enhance immunity, and regulate the central nervous system.
How is the Panax Quinquefolius market segmented by type?
By type, the market is segmented into Dried Ginseng and Wet Ginseng.
What are the key applications of Panax Quinquefolius?
Key applications covered include Medicine and Food and Health Products.
Which companies are profiled in the Panax Quinquefolius market report?
Key players profiled include Hsu’s, WOHO, Great Mountain Ginseng, Tongrentang, Shanghai Leiyunshang Pharmaceutical, Globrand, Kangmei Xinkaihe and Canadian Ginseng Farm Shop, among 19 companies covered in total.
What geographies does the Panax Quinquefolius market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Panax Quinquefolius?
The global American ginseng (Panax quinquefolius) market has maintained steady growth, driven by rising health awareness, expanding demand for immune-support supplements, and the internationalization of traditional Chinese medicine.
What are the main risks and barriers in the Panax Quinquefolius market?
However, climatic constraints and soil rotation requirements cause raw material price fluctuations, making future development increasingly reliant on improved varieties, modern cultivation management, and global market expansion.
Who should buy the Panax Quinquefolius market report?
The report is intended for manufacturers and solution providers, distributors and end users in Medicine and Food and Health Products, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Panax Quinquefolius market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.